In addition to the effects of CCL17 on hematoma resolution, the axis also could alleviate neuroinflammation and neuronal apoptosis via the CCR4/PI3K/AKT/Foxo1 signaling pathway at 72 h post-ICH (Deng et al., 2021). Here, CCR4 is linked to hematoma.